Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.
10.4111/kju.2015.56.5.337
- Author:
Nikolas Christopher KATELARIS
1
;
Damien Michael BOLTON
;
Mahesha WEERAKOON
;
Liam TONER
;
Phillip Mark KATELARIS
;
Nathan LAWRENTSCHUK
Author Information
1. Department of Surgery, Austin Hospital, University of Melbourne, Melbourne, VIC, Australia. lawrentschuk@gmail.com
- Publication Type:Review
- Keywords:
Diagnosis;
Magnetic resonance imaging;
Pathology;
Prostatic neoplasms;
Urology
- MeSH:
*Disease Management;
Humans;
Magnetic Resonance Imaging/*methods;
Male;
Prostate/*pathology;
Prostate-Specific Antigen/blood;
Prostatectomy;
Prostatic Neoplasms/*diagnosis/pathology/surgery
- From:Korean Journal of Urology
2015;56(5):337-345
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this review was to evaluate the current role of multiparametric magnetic resonance imaging (mp-MRI) in the management of prostate cancer (PC). The diagnosis of PC remains controversial owing to overdetection of indolent disease, which leads to overtreatment and subsequent patient harm. mp-MRI has the potential to equilibrate the imbalance between detection and treatment. The limitation of the data for analysis with this new technology is problematic, however. This issue has been compounded by a paradigm shift in clinical practice aimed at utilizing this modality, which has been rolled out in an ad hoc fashion often with commercial motivation. Despite a growing body of literature, pertinent clinical questions remain. For example, can mp-MRI be calibrated to reliably detect biologically significant disease? As with any new technology, objective evaluation of the clinical applications of mp-MRI is essential. The focus of this review was on the evaluation of mp-MRI of the prostate with respect to clinical utility.
